Biotechnology Lab

Medical Innovators: AXIM Biotech’s Proprietary cGMP Extraction and Manufacturing Approach Revolutionizes Industry

The world of medical marijuana research is rapidly changing, and recent news within the industry shows that some important innovations have developed which could revolutionize the landscape. AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, recently announced the first-ever successful execution of proprietary current good manufacturing practices (“cGMP”) methods to extract…

Medical Cannabis Drug Watch: GW Pharmaceuticals is again hoping to get another approval from FDA

GW Pharmaceuticals (NASDAQ: GWPH, GW, the Company or the Group), a British medical cannabis company, is known to be dedicated to the development of plant-based cannabinoid drugs. For the past 20 years, the company has been studying about the medical benefits of cannabis. Since 1998, GW Pharmaceuticals has been focusing on the treatment of different…

Kenyan Government Invests in Biotech Cotton to Provide More Jobs to Farmers

Just recently, the government of Kenya is banking on the mass production of biotech (or genetically modified) cotton plants to provide about 50,000 jobs to its citizens. Such bold action is part of current President Uhuru Kenyatta’s economic revival plan. Aside from that, the plan also covers the review of Kenya’s other policies and the…

Hypersexual disorder: Prevalence in patients with Frontotemporal Dementia and Alzheimer’s Disease

According to scientific studies, numerous neurological disorders like dementia, multiple sclerosis, cerebral anoxia, and Parkinsonian disorders can lead to the alterations of sexual behavior. Aside from experiencing neurological problems, patients may either experience inhibited sexual interest (known as hyposexuality) or greatly increased sexual desire (hypersexuality).   Over the past decades, increasing cases of hypersexual behavior…

Medical Marijuana: World Health Organization Announces CBD No Longer A Scheduled Drug

At the end of last year, the World Health Organization announced that cannabidiol (CBD) will no longer be considered a scheduled drug. During its five-day November meeting, CBD was one of the 16 substances that were reevaluated in terms of accepted international regulations — and most industry analysts have suggested that the potential market upside…

Cancer Treatments: Cure Pharmaceuticals’ New Data on Cannabis Could Be A Breakthrough

In the market today, the global wellness industry is considered to be one of the highest valued industries worldwide, amounting to more than $3.7 trillion in sales each year.  One reason for this lies in the fact that the industry generally covers a broad scope from public health to personalized medications and supplements. Aside from…

Scroll to top